| lipovirtide (LP-80) / Shanxi Kangbao Bio |
NCT06061536: Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. |
|
|
| Recruiting | 2 | 64 | RoW | Lipovirtide 10mg, 3TC, TDF, Lipovirtide 40mg, Lipovirtide 60mg, DTG | Shanxi Kangbao Biological Product Co., Ltd., Institute of Pathogen Biology, Chinese Academy of Medical Sciences | HIV | 12/24 | 12/24 | | |
ChiCTR2000038491: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-Infected Patients without Prior Antiviral Therapy |
|
|
| Recruiting | 1 | 46 | | single-dose ;single-dose ;single-dose ;single-dose ;single-dose ;single-dose | Beijing You'an Hospital Affiliated to Capital Medical University; Institute of Pathogen Biology, Chinese Academy of Medical Sciences, SHANXI KANGBAO BIOLOGICAL PRODUCT CO., LTD | HIV infections | | | | |
ChiCTR2200059356: A clinical study to evaluate the safety, pharmacokinetics and efficacy of multiple dosing of Lipovirtide for injection in HIV-infected patients who have not received antiretroviral therapy |
|
|
| Not yet recruiting | 1 | 24 | | 5mg ;20mg ;40mg | Beijing You'an Hospital Afliated to Capital Medical University; Institute of Pathogen Biology, Chinese Academy of Medical Sciences, SHANXI KANGBAO BIOLOGICAL PRODUCT CO.,LTD | HIV infections | | | | |
NCT04592315: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients |
|
|
| Completed | 1 | 46 | RoW | Lipovirtide Injection | Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences | HIV Infections | 05/23 | 07/23 | | |
NCT05349968: Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients |
|
|
| Completed | 1 | 24 | RoW | Lipovirtide for injection, nothing | Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences | HIV Infections | 06/23 | 09/23 | | |
